Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.
A combination treatment delivered to the site of fractures may improve bone healing in patients with the genetic disease neurofibromatosis type-1.
A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.
Two proteins interact to maintain selenium levels in the brain, and protect neurons from degeneration.
It may be possible to use skin cells as biomarkers to diagnose and manage depression.
Vanderbilt researchers have identified a new target for blocking breast cancer metastasis.